| scholarly article | Q13442814 |
| P2093 | author name string | R S Evans | |
| J P Burke | |||
| D C Classen | |||
| J F Lloyd | |||
| S L Pestotnik | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| hospitalization | Q3140971 | ||
| P304 | page(s) | 301-306 | |
| P577 | publication date | 1997-01-01 | |
| P1433 | published in | The Journal of the American Medical Association | Q1470970 |
| P1476 | title | Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. | |
| P478 | volume | 277 |
| Q64087296 | "Hopefully, I will never forget that again" - sensitizing medical students for drug safety by working on cases and simulating doctor-patient communication |
| Q37210164 | 'Relation, association, attribution ...' - the multiple faces of death in critical care medicine |
| Q37335836 | 2009 Rho Chi Lecture: interdisciplinary health professions education: a systems approach to bridging the gaps |
| Q30979182 | A Method to Combine Signals from Spontaneous Reporting Systems and Observational Healthcare Data to Detect Adverse Drug Reactions |
| Q47219753 | A User-Centered Glucose-Insulin Data Display for the Inpatient Setting |
| Q40384219 | A baseline study of medication error rates at Baylor University Medical Center in preparation for implementation of a computerized physician order entry system |
| Q41820478 | A clinical rules taxonomy for the implementation of a computerized physician order entry (CPOE) system |
| Q36485766 | A comparison of active surveillance programs including a spontaneous reporting model for phamacovigilance of adverse drug events in a hospital. |
| Q41948738 | A computerized reminder for prophylaxis of deep vein thrombosis in surgical patients |
| Q37511063 | A drug database model as a central element for computer-supported dose adjustment within a CPOE system |
| Q37287907 | A drug interactions elective course |
| Q37040215 | A method for systematic discovery of adverse drug events from clinical notes |
| Q39117510 | A multicenter record review of in-hospital adverse drug events requiring a higher level of care |
| Q50674440 | A prospective three-step intervention study to prevent medication errors in drug handling in paediatric care. |
| Q42943041 | A purging procedure for pantoprazole and 4-lumen catheters to prevent IV drug incompatibilities |
| Q34612789 | A quantitative evaluation of medication histories and reconciliation by discipline |
| Q33950627 | A randomized trial of "corollary orders" to prevent errors of omission |
| Q41866041 | A randomized, controlled trial of a clinical pharmacist intervention in microdiscectomy surgery - Low dose intravenous ketamine as an adjunct to standard therapy |
| Q89893028 | A super-combo-drug test to detect adverse drug events and drug interactions from electronic health records in the era of polypharmacy |
| Q36622521 | A survey on the knowledge, attitude and the practice of pharmacovigilance among the health care professionals in a teaching hospital in northern India |
| Q28079380 | A systematic review of observational studies evaluating costs of adverse drug reactions |
| Q36463193 | A systematic review of the performance characteristics of clinical event monitor signals used to detect adverse drug events in the hospital setting |
| Q38831766 | A systematic review of the prevalence and incidence of prescribing errors with high-risk medicines in hospitals. |
| Q35619108 | A systematic review to evaluate the accuracy of electronic adverse drug event detection |
| Q35012194 | A time-indexed reference standard of adverse drug reactions |
| Q33775257 | A trial of automated decision support alerts for contraindicated medications using computerized physician order entry |
| Q35179698 | A trial of automated safety alerts for inpatient digoxin use with computerized physician order entry. |
| Q80508798 | ASHP long-range vision for the pharmacy work force in hospitals and health systems: ensuring the best use of medicines in hospitals and health systems |
| Q44616789 | Absolute contraindications in relation to potential drug interactions in outpatient prescriptions: analysis of the first five million prescriptions in 1999. |
| Q44699697 | Absolute contraindications in relation to potential drug interactions in outpatient prescriptions: analysis of the first five million prescriptions in 1999. |
| Q33700367 | Academic detailing improves identification and reporting of adverse drug events. |
| Q39291766 | Addressing Inpatient Beta-Lactam Allergies: A Multihospital Implementation |
| Q30885039 | Administrative data based patient safety research: a critical review |
| Q45943118 | Adverse Drug Event Discovery Using Biomedical Literature: A Big Data Neural Network Adventure. |
| Q35917334 | Adverse Drug Event Ontology: Gap Analysis for Clinical Surveillance Application. |
| Q38741777 | Adverse Drug Events in Patients with Mental Disorder in an Ambulatory Setting |
| Q34501394 | Adverse Drug Reactions (ADR) in the inPatients of Medicine Department of a Rural Tertiary Care Teaching Hospital and Influence of Pharmacovigilance in Reporting ADR. |
| Q46454391 | Adverse Drug Reactions in Children--International Surveillance and Evaluation (ADVISE): a multicentre cohort study |
| Q54948520 | Adverse Drug Reactions in Hospitalized Patients: Results of the FORWARD (Facilitation of Reporting in Hospital Ward) Study. |
| Q64075957 | Adverse Event Circumstances and the Case of Drug Interactions |
| Q79159570 | Adverse drug effects observed at French admissions departments and emergency services (Prospective study of the National Educational Association for Teaching Therapeutics and proposals for preventive measures |
| Q33611340 | Adverse drug event rates in six community hospitals and the potential impact of computerized physician order entry for prevention |
| Q35526139 | Adverse drug event trigger tool: a practical methodology for measuring medication related harm |
| Q37683726 | Adverse drug events among hospitalized Medicare patients: epidemiology and national estimates from a new approach to surveillance |
| Q44762942 | Adverse drug events among patients receiving postsurgical opioids in a large health system: risk factors and outcomes |
| Q36939773 | Adverse drug events and medication errors in psychiatry: methodological issues regarding identification and classification |
| Q38026024 | Adverse drug events caused by serious medication administration errors |
| Q36980380 | Adverse drug events during AKI and its recovery |
| Q35691131 | Adverse drug events in hospitalized children at Ethiopian University Hospital: a prospective observational study |
| Q44018627 | Adverse drug events in hospitalized patients treated with cardiovascular drugs and anticoagulants |
| Q45158316 | Adverse drug events in patients admitted to an emergency department: an analysis of direct costs |
| Q34101662 | Adverse drug events in the outpatient setting: an 11-year national analysis |
| Q36535824 | Adverse drug reaction monitoring in a secondary care hospital in South India |
| Q24524192 | Adverse drug reactions |
| Q78073561 | Adverse drug reactions as a cause for admissions to a department of internal medicine |
| Q28169189 | Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients |
| Q38628506 | Adverse drug reactions in children: a ten-year review of reporting to the Portuguese Pharmacovigilance System |
| Q28474740 | Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes |
| Q35052339 | Adverse drug reactions in inpatients of internal medicine wards at a tertiary care hospital: A prospective cohort study |
| Q34644792 | Adverse drug reactions monitoring: prospects and impending challenges for pharmacovigilance. |
| Q28193890 | Adverse drugs reactions: diagnosis and assessment |
| Q37306734 | Adverse events during hospitalization: results of a patient survey |
| Q64289332 | Adverse events during intrahospital transport of critically ill patients in a large hospital |
| Q92858046 | Adverse reactions of Amiodarone |
| Q59652653 | Adverse-drug-event rates for high-cost and high-use drugs in the intensive care unit |
| Q93922805 | Advertising prescription-only drugs |
| Q36526533 | An observational study of adult admissions to a medical ICU due to adverse drug events |
| Q35951342 | An ounce of prevention: a pound of cure for an ailing health care system. |
| Q43373061 | Analysis of Adverse Events during Intrahospital Transportation of Critically Ill Patients. |
| Q37859630 | Analysis of cost avoidance from pharmacy students' clinical interventions at a psychiatric hospital |
| Q41577389 | Analyzing search behavior of healthcare professionals for drug safety surveillance |
| Q49865574 | Antibiotic-Related Adverse Drug Reactions at a Tertiary Care Hospital in South Korea. |
| Q33992514 | Antiretroviral prescribing errors in hospitalized patients |
| Q34145767 | Apolipoprotein E genotyping for pharmacogenetic purposes in Alzheimer's disease: emerging ethical issues |
| Q83016837 | Applying Lean Sigma solutions to mistake-proof the chemotherapy preparation process |
| Q36969326 | Appropriateness of drug dose and frequency in patients with renal dysfunction in a tertiary care hospital: A cross-sectional study |
| Q79155033 | Assessing explicit error reporting in the narrative electronic medical record using keyword searching |
| Q34000905 | Assessing medication appropriateness in the elderly: a review of available measures |
| Q60619208 | Assessing the Feasibility of Using an Adverse Drug Reaction Preventability Scale in Clinical Practice |
| Q35154708 | Assessing the economic impact of adverse drug effects |
| Q35625100 | Assessing the usability of a telemedicine-based Medication Delivery Unit for older adults through inspection methods. |
| Q34085099 | Assessment of adherence to renal dosing guidelines in long-term care facilities |
| Q79337305 | Assessment of adverse drug events among patients in a tertiary care medical center |
| Q38688003 | Assessment of drug-related problems in pediatric ward of Zewditu Memorial Referral Hospital, Addis Ababa, Ethiopia |
| Q36809811 | Assessment of statin-associated muscle toxicity in Japan: a cohort study conducted using claims database and laboratory information |
| Q33431895 | Association between Total Daily Doses with duration of hospitalization among readmitted patients in a multi-ethnic Asian population |
| Q100504044 | Association between neonatal intensive care unit medication safety practices, adverse events, and death |
| Q40628800 | Automated identification of antibiotic overdoses and adverse drug events via analysis of prescribing alerts and medication administration records. |
| Q34881857 | Automatically Recognizing Medication and Adverse Event Information From Food and Drug Administration's Adverse Event Reporting System Narratives. |
| Q42626241 | Awareness and reporting of adverse drug reactions among health care professionals in Sudan |
| Q24813204 | Bench-to-bedside review: antimicrobial utilization strategies aimed at preventing the emergence of bacterial resistance in the intensive care unit |
| Q37396729 | Benzodiazepine prescription and length of hospital stay at a Japanese university hospital |
| Q35764731 | Biclustering of adverse drug events in the FDA's spontaneous reporting system. |
| Q34056343 | Brief intervention to increase emergency department uptake of combined rapid human immunodeficiency virus and hepatitis C screening among a drug misusing population |
| Q40320786 | Burden of hospitalizations related to adverse drug events in the USA: a retrospective analysis from large inpatient database. |
| Q88763523 | CYP2D6 Allelic Variants *34, *17-2, *17-3, and *53 and a Thr309Ala Mutant Display Altered Kinetics and NADPH Coupling in Metabolism of Bufuralol and Dextromethorphan and Altered Susceptibility to Inactivation by SCH 66712 |
| Q45045807 | Calculation of doses of drugs in solution: are medical students confused by different means of expressing drug concentrations? |
| Q51936565 | Can decisional algorithms replace global introspection in the individual causality assessment of spontaneously reported ADRs? |
| Q38093137 | Cancer pharmacogenomics in children: research initiatives and progress to date. |
| Q47339342 | Categorization and association analysis of risk factors for adverse drug events |
| Q33745957 | Characteristics of ambulatory anticoagulant adverse drug events: a descriptive study |
| Q43457802 | Characteristics of medication errors and adverse drug events in hospitals participating in the California Pediatric Patient Safety Initiative |
| Q46338008 | Characterizing adverse events reported to the California Poison Control System on herbal remedies and dietary supplements: a pilot study |
| Q34410054 | Checking it twice: an evaluation of checklists for detecting medication errors at the bedside using a chemotherapy model |
| Q45899695 | Chiropractic care of the older person: developing an evidence-based approach. |
| Q37676434 | Classification-by-Analogy: Using Vector Representations of Implicit Relationships to Identify Plausibly Causal Drug/Side-effect Relationships |
| Q57159654 | Clinical Decision Support Systems for Drug Allergy Checking: Systematic Review |
| Q30234940 | Clinical Implications of P-Glycoprotein Modulation in Drug-Drug Interactions. |
| Q38846776 | Clinical Information Systems - From Yesterday to Tomorrow |
| Q92384678 | Clinical Judgement Study using Question Answering from Electronic Health Records |
| Q55119565 | Clinical Relation Extraction Toward Drug Safety Surveillance Using Electronic Health Record Narratives: Classical Learning Versus Deep Learning. |
| Q37369674 | Clinical and economic burden of adverse drug reactions |
| Q30736637 | Clinical and financial impact of intravenous erythromycin therapy in hospitalized patients |
| Q44440863 | Clinical associations of delirium in hospitalized adult patients and the role of on admission presentation. |
| Q35779097 | Clinical informatics in critical care |
| Q39216376 | Clinical medication review tool for polypharmacy: Mapping approach for pharmacotherapeutic classifications. |
| Q44613336 | Clinical outcomes from the use of Medication Report when elderly patients are discharged from hospital |
| Q37121998 | Clinical review: medication errors in critical care |
| Q33534804 | Clinically significant drug interactions. |
| Q36243905 | Clinician use of a palmtop drug reference guide |
| Q37676549 | Cognitive Errors in Reconciling Complex Medication Lists |
| Q61964756 | Combined intervention programme reduces inappropriate prescribing in elderly patients exposed to polypharmacy in primary care |
| Q36771112 | Combing signals from spontaneous reports and electronic health records for detection of adverse drug reactions |
| Q40612462 | Community pharmacists' perspectives on pharmaceutical care implementation in New Zealand |
| Q47628038 | Comparative Cost-Effectiveness Analysis of Three Different Automated Medication Systems Implemented in a Danish Hospital Setting. |
| Q51412946 | Comparative evaluation of three clinical decision support systems: prospective screening for medication errors in 100 medical inpatients. |
| Q50718741 | Comparative performance of two drug interaction screening programmes analysing a cross-sectional prescription dataset of 84,625 psychiatric inpatients. |
| Q36782901 | Comparing the effectiveness of computerized adverse drug event monitoring systems to enhance clinical decision support for hospitalized patients |
| Q41414103 | Comparing the performance of the Charlson/Deyo and Elixhauser comorbidity measures across five European countries and three conditions |
| Q35082994 | Comparison of computerized surveillance and manual chart review for adverse events |
| Q47996772 | Comparison of drug-related problems in different patient groups |
| Q36470184 | Comparison of knowledge, attitude and practices of resident doctors and nurses on adverse drug reaction monitoring and reporting in a tertiary care hospital |
| Q38568408 | Comparison of tools for the assessment of inappropriate prescribing in hospitalized older people |
| Q36461133 | Comparison of two knowledge bases on the detection of drug-drug interactions. |
| Q35726156 | Compliance with dosing guidelines in patients with chronic kidney disease |
| Q36085359 | Comprehensive analysis of a medication dosing error related to CPOE |
| Q30356168 | Computerized decision support systems: improving patient safety in nephrology. |
| Q39025617 | Computerized pharmacy surveillance and alert system for drug-related problems. |
| Q36488502 | Computerized physician order entry: helpful or harmful? |
| Q73249662 | Computerized physician-order entry: are we there yet? |
| Q33708280 | Computerized protocols and bedside decision support |
| Q33969571 | Computerized survelliance of adverse drug reactions in hospital: pilot study |
| Q57036724 | Conceptualising production, productivity and technology in pharmacy practice: a novel framework for policy, education and research |
| Q73283686 | Consumers' willingness to pay for pharmacy services that reduce risk of medication-related problems |
| Q38614898 | Content and Usability Evaluation of Patient Oriented Drug-Drug Interaction Websites |
| Q30611776 | Cost and quality implications of opioid-based postsurgical pain control using administrative claims data from a large health system: opioid-related adverse events and their impact on clinical and economic outcomes |
| Q46469027 | Cost comparison of drug-drug and drug-condition interactions in patients with painful diabetic peripheral neuropathy treated with pregabalin versus duloxetine |
| Q44970881 | Cost of adverse drug reactions in a South Indian tertiary care teaching hospital. |
| Q44340622 | Cost of opioid-related adverse drug events in surgical patients |
| Q53231509 | Cost-effectiveness of one-time genetic testing to minimize lifetime adverse drug reactions. |
| Q35151219 | Cost-outcome description of clinical pharmacist interventions in a university teaching hospital |
| Q36741428 | Costs associated with developing and implementing a computerized clinical decision support system for medication dosing for patients with renal insufficiency in the long-term care setting |
| Q33761456 | Counting the costs of drug-related adverse events |
| Q49853822 | Critical Care Pharmacists and Medication Management in an ICU Recovery Center. |
| Q73447802 | Critical pathways: what do you do when they do not seem to work? |
| Q37398415 | Current status of the monitoring of medication practice |
| Q34125401 | Dangerous and common drug interactions in patients with diabetes mellitus |
| Q24599300 | Data-driven prediction of drug effects and interactions |
| Q35524736 | Decision support and safety of clinical environments |
| Q47292895 | Decreased Rates of Inpatient Hypoglycemia Following Implementation of an Automated Tool in the Electronic Medical Record for Identifying Root Causes |
| Q46155882 | Design of a score to identify hospitalized patients at risk of drug-related problems. |
| Q37230723 | Designing an Adverse Drug Event Reporting System to Prevent Unintentional Reexposures to Harmful Drugs: Study Protocol for a Multiple Methods Design. |
| Q78502378 | Desire for information about drugs: relationships with patients' characteristics and adverse effects |
| Q81688125 | Detecting adverse drug reactions on paediatric wards: intensified surveillance versus computerised screening of laboratory values |
| Q35557303 | Detecting adverse events for patient safety research: a review of current methodologies |
| Q44653015 | Detecting medication errors in the New Zealand pharmacovigilance database: a retrospective analysis. |
| Q40615203 | Detection of Patients at High Risk of Medication Errors: Development and Validation of an Algorithm. |
| Q74587468 | Detection of adverse drug reactions in a neurological department: comparison between intensified surveillance and a computer-assisted approach |
| Q43414004 | Determining the frequency of prescription errors in an Irish hospital |
| Q55547098 | Developing a Taxonomy for Research in Adverse Drug Events: Potholes and Signposts. |
| Q79830187 | Developing a model to determine the effects of adverse drug events in hospital inpatients |
| Q34515318 | Developing a taxonomy for research in adverse drug events: potholes and signposts. |
| Q38532870 | Development of a collaborative transitions-of-care program for heart failure patients |
| Q90181834 | Development of a standardized chart review method to identify drug-related hospital admissions in older people |
| Q36767129 | Development of the Leapfrog methodology for evaluating hospital implemented inpatient computerized physician order entry systems |
| Q28550754 | Differences between Drug-Induced and Contrast Media-Induced Adverse Reactions Based on Spontaneously Reported Adverse Drug Reactions |
| Q45942394 | Direct-to-consumer pharmacogenomic testing is associated with increased physician utilisation. |
| Q41117470 | Does electronic medication reconciliation at hospital discharge decrease prescription medication errors? |
| Q30450174 | Does national regulatory mandate of provider order entry portend greater benefit than risk for health care delivery? The 2001 ACMI debate. The American College of Medical Informatics. |
| Q40279591 | Drug Fever: a descriptive cohort study from the French national pharmacovigilance database. |
| Q90249986 | Drug Hypersensitivity Reactions Documented in Electronic Health Records within a Large Health System |
| Q33864006 | Drug complications in outpatients |
| Q28367622 | Drug dosage in patients with renal failure optimized by immediate concurrent feedback |
| Q26822023 | Drug hypersensitivity reactions targeting the skin in dogs and cats |
| Q59278178 | Drug identification and interaction checker based on IoT to minimize adverse drug reactions and improve drug compliance |
| Q36055131 | Drug interactions avoided-a useful indicator of good prescribing practice |
| Q44701900 | Drug interactions. Mechanisms and clinical relevance |
| Q34631498 | Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity |
| Q24807044 | Drug therapy and adverse drug reactions to terbutaline in obstetric patients: a prospective cohort study in hospitalized women |
| Q41740941 | Drug therapy: the impact of managed care |
| Q38383012 | Drug-drug interaction discovery and demystification using Semantic Web technologies |
| Q36500491 | Drug-drug interaction through molecular structure similarity analysis. |
| Q47927135 | Drug-induced blood consumption: the impact of adverse drug reactions on demand for blood components in German departments of internal medicine |
| Q50673371 | Drug-related morbidity and mortality: updating the cost-of-illness model. |
| Q33903082 | Drug-related problems in hospitalised patients. |
| Q35166646 | Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender |
| Q36807983 | Drug-related problems in hospitals: a review of the recent literature |
| Q37193986 | E-pharmacovigilance: development and implementation of a computable knowledge base to identify adverse drug reactions |
| Q91869143 | Economic analysis of implementing virtual reality therapy for pain among hospitalized patients |
| Q39572002 | Economic contributions of pharmaceutical interventions by pharmacists: a retrospective report in Japan |
| Q28084632 | Educating medical trainees on medication reconciliation: a systematic review |
| Q36397114 | Effect of Pharmacy-Supported Transition-of-Care Interventions on 30-Day Readmissions: A Systematic Review and Meta-analysis |
| Q45374191 | Effect of adverse drug reactions on length of stay in intensive care units |
| Q97524511 | Effect of educational intervention on awareness of pharmacovigilance among medical undergraduates in a tertiary care teaching hospital |
| Q44337448 | Effect of opioid-related adverse events on outcomes in selected surgical patients |
| Q43535446 | Effects of an adverse-drug-event alert system on cost and quality outcomes in community hospitals. |
| Q37076950 | Effects of non-severe acute kidney injury on clinical outcomes in critically ill patients |
| Q28544992 | Effects of polypharmacy on adverse drug reactions among geriatric outpatients at a tertiary care hospital in Karachi: a prospective cohort study |
| Q35810582 | Effects of self-empowered teams on rates of adverse drug events in primary care |
| Q37798656 | Efficiency and applicability of comprehensive geriatric assessment in the emergency department: a systematic review |
| Q33966731 | Efficiency and usability of a near field communication-enabled tablet for medication administration |
| Q37540904 | Emergency department visits and admissions due to drug related problems at Riyadh military hospital (RMH), Saudi Arabia |
| Q53015365 | Emergency department visits caused by adverse drug events: results of a French survey. |
| Q48639664 | Emergency medicine pharmacy practice. |
| Q38432457 | Empowering frontline nurses: a structured intervention enables nurses to improve medication administration accuracy |
| Q38027665 | Enhancements in healthcare information technology systems: customizing vendor-supplied clinical decision support for a high-risk patient population |
| Q38014315 | Epidemiology and potential associated risk factors of drug-related problems in hospitalised children in the United Kingdom and Saudi Arabia. |
| Q33603755 | Epidemiology of adverse drug reactions in the elderly by drug class |
| Q42711451 | Epidemiology of medical error |
| Q24524722 | Epidemiology of medical error |
| Q51972418 | Epidemiology, comparative methods of detection, and preventability of adverse drug events. |
| Q37990832 | Errors in fluid therapy in medical wards |
| Q34612863 | Estimated cost savings from reducing errors in the preparation of sterile doses of medications |
| Q24800254 | Estimates of complications of medical care in the adult US population |
| Q37447614 | Estimating the Effect of Intravenous Acetaminophen for Postoperative Pain Management on Length of Stay and Inpatient Hospital Costs |
| Q43797286 | Estimation of creatinine clearance in elderly persons in long-term care facilities |
| Q42758914 | Estimation of time devoted to adverse drug reactions assessment in an internal medicine department |
| Q34743306 | Ethical perspectives on pharmacogenomic profiling in the drug development process |
| Q51920095 | Ethical problems in pharmacogenetic studies of psychiatric disorders. |
| Q37343568 | Ethnic variations in unplanned readmissions and excess length of hospital stay: a nationwide record-linked cohort study |
| Q40594451 | Evaluating the capability of information technology to prevent adverse drug events: a computer simulation approach |
| Q38163956 | Evaluating the impact of telepharmacy |
| Q41872764 | Evaluating the potential effectiveness of using computerized information systems to prevent adverse drug events. |
| Q90137496 | Evaluation of Harm Associated with High Dose-Range Clinical Decision Support Overrides in the Intensive Care Unit |
| Q88616512 | Evaluation of a Novel System to Enhance Clinicians' Recognition of Preadmission Adverse Drug Reactions |
| Q44507755 | Evaluation of a computer-assisted antibiotic-dose monitor |
| Q37329800 | Evaluation of a computer-based adverse-drug-event monitor |
| Q39606805 | Evaluation of adverse drug reactions in medical intensive care units. |
| Q37376716 | Evaluation of adverse reactions to contrast media in the hospital. |
| Q33403050 | Evaluation of appropriate serologic testing for suspected heparin-induced thrombocytopenia. |
| Q64237020 | Evaluation of community pharmacists' knowledge about drug-drug interaction in Central Saudi Arabia |
| Q59586711 | Evaluation of compliance with a computerized protocol: Weaning from mechanical ventilator support using pressure support |
| Q91934922 | Evaluation of drug utilization in cardiovascular disease at a teaching and referral hospital in Northern Telangana |
| Q45331297 | Evaluation of medication safety in the discharge medication of 509 surgical inpatients using electronic prescription support software and an extended operational interaction classification |
| Q35731407 | Evolution of a Rapid Hydration Protocol |
| Q26800980 | Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response. |
| Q36244430 | Examining nurses' decision process for medication management in home care. |
| Q39869148 | Excess cost and length of stay associated with voluntary patient safety event reports in hospitals |
| Q35857749 | Excess length of stay and economic consequences of adverse events in Dutch hospital patients |
| Q44811768 | Exploring the relationship between costs and quality: does the joint evaluation of costs and quality alter the ranking of Danish hospital departments? |
| Q90577084 | Extracting medications and associated adverse drug events using a natural language processing system combining knowledge base and deep learning |
| Q60940065 | Extraction of Information Related to Adverse Drug Events from Electronic Health Record Notes: Design of an End-to-End Model Based on Deep Learning |
| Q90136594 | Factors affecting patient safety culture among dental healthcare workers: A nationwide cross-sectional survey |
| Q64944721 | Factors associated with adverse drug reaction occurrence and prognosis, and their economic impacts in older inpatients in Taiwan: a nested case-control study. |
| Q80935490 | Factors influencing bar-code verification by nurses during medication administration in a Dutch hospital |
| Q41953586 | Factors predictive of intravenous fluid administration errors in Australian surgical care wards |
| Q41126993 | Factors that affect adverse drug reaction reporting among hospital pharmacists in Western China |
| Q40955862 | Filtering Entities to Optimize Identification of Adverse Drug Reaction From Social Media: How Can the Number of Words Between Entities in the Messages Help? |
| Q47382768 | Findings from the ISMP Medication Safety Self-Assessment® for Hospitals |
| Q45770401 | First Experiences with a Simple Patient INTERNET Program for Drug Risk Checking |
| Q49645888 | Frequency and Impact of Adverse Events in Inpatients: A Nationwide Analysis of Episodes between 2000 and 2015. |
| Q35802171 | Frequency and cost of serious adverse drug reactions in a department of general medicine |
| Q80531534 | Frequency and preventability of adverse drug reactions in paediatric patients |
| Q40621456 | Frequency of and risk factors for medication errors by pharmacists during order verification in a tertiary care medical center |
| Q34700802 | Frequency of medication errors in an emergency department of a large teaching hospital in southern Iran |
| Q39826476 | Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital |
| Q28469155 | Function-altering SNPs in the human multidrug transporter gene ABCB1 identified using a Saccharomyces-based assay |
| Q64247085 | Gaps, traps, bridges and props: a mixed-methods study of resilience in the medicines management system for patients with heart failure at hospital discharge |
| Q38233757 | Genotype-guided drug prescribing: a systematic review and meta-analysis of randomized control trials |
| Q50061469 | Goals and Objectives to Optimize the Value of an Acute Pain Service in Perioperative Pain Management. |
| Q37730497 | Harnessing scientific literature reports for pharmacovigilance. Prototype software analytical tool development and usability testing |
| Q39480907 | Health information technology adoption in U.S. acute care hospitals |
| Q36608310 | Health information technology will shift the medical care paradigm |
| Q37283176 | Health literacy in the pharmacy setting: defining pharmacotherapy literacy. |
| Q37283188 | Health professionals' knowledge, attitude and practices towards pharmacovigilance in Nepal |
| Q36443637 | Healthcare reform from the inside: A neurosurgical clinical quality program |
| Q34243928 | Hope modified the association between distress and incidence of self-perceived medical errors among practicing physicians: prospective cohort study |
| Q37286903 | Hospital Clostridium difficile Infection Rates and Prediction of Length of Stay in Patients Without C. difficile Infection |
| Q57688913 | Hospitalisation in short-stay units for adults with internal medicine diseases and conditions |
| Q58040954 | Hospitalisation in short-stay units for internal medicine diseases and conditions |
| Q26851206 | Hospitalization and cognitive decline: Can the nature of the relationship be deciphered? |
| Q37975521 | How are the costs of drug-related morbidity measured?: a systematic literature review |
| Q39778841 | How can we enable drug discovery informatics for personalized healthcare? |
| Q47225802 | How should medication errors be defined? Development and test of a definition |
| Q81061872 | How to design computerized alerts to safe prescribing practices |
| Q50150452 | How well does diagnosis-based risk-adjustment work for comparing ambulatory clinical outcomes? |
| Q35170780 | Human errors in medical practice: systematic classification and reduction with automated information systems |
| Q39050993 | Human iPSC-derived cardiomyocytes and tissue engineering strategies for disease modeling and drug screening |
| Q35039980 | ICD-10 codes used to identify adverse drug events in administrative data: a systematic review |
| Q43136270 | Iatrogenic events contributing to ICU admission: a prospective study. |
| Q38937249 | Identification and Characterization of Adverse Drug Events in Primary Care. |
| Q73698793 | Identification of adverse drug reactions in geriatric inpatients using a computerised drug database |
| Q45769651 | Identifying Hospital Admissions Due to Adverse Drug Events: Using a Computer-Based Monitor |
| Q38681717 | Identifying the common genetic networks of ADR (adverse drug reaction) clusters and developing an ADR classification model |
| Q30487733 | Impact of Inpatient Harms on Hospital Finances and Patient Clinical Outcomes |
| Q38164660 | Impact of a clinical pharmacy admission medication reconciliation program on medication errors in "high-risk" patients. |
| Q43272333 | Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease |
| Q38844267 | Impact of commercial computerized provider order entry (CPOE) and clinical decision support systems (CDSSs) on medication errors, length of stay, and mortality in intensive care units: a systematic review and meta-analysis |
| Q28194958 | Impact of computerized physician order entry on medication prescription errors in the intensive care unit: a controlled cross-sectional trial |
| Q36278577 | Impact of early in-hospital medication review by clinical pharmacists on health services utilization |
| Q37802102 | Impact of health information technology on detection of potential adverse drug events at the ordering stage |
| Q35957556 | Impact of inappropriate drug use on health services utilization among representative older community-dwelling residents |
| Q90532893 | Impact of medication therapy management on pharmacotherapy safety in an intensive care unit |
| Q43945933 | Implementation and evaluation of carousel dispensing technology in a university medical center pharmacy |
| Q47171800 | Implementation of an IT-guided checklist to improve the quality of medication history records at hospital admission. |
| Q35645605 | Implementation of an audit with feedback knowledge translation intervention to promote medication error reporting in health care: a protocol |
| Q79771447 | Implementation of an electronic system for medication reconciliation |
| Q39698013 | Implementation of hospital computerized physician order entry systems in a rural state: feasibility and financial impact. |
| Q54374494 | Implementation of inpatient models of pharmacogenetics programs. |
| Q46127892 | Implementing Computerized Provider Order Entry in Acute Care Hospitals in the United States Could Generate Substantial Savings to Society. |
| Q37167702 | Implementing the Use of Pharmacist Progress Notes in a Surgical ICU. |
| Q34051874 | Improved statistical signal detection in pharmacovigilance by combining multiple strength-of-evidence aspects in vigiRank. |
| Q80439455 | Improvement in the handling of drug-drug interactions |
| Q38084626 | Improving adverse drug event detection in critically ill patients through screening intensive care unit transfer summaries |
| Q94326415 | Improving adverse drug event reporting by health care professionals |
| Q38835088 | Improving drug safety: From adverse drug reaction knowledge discovery to clinical implementation |
| Q35527728 | Improving medication management for patients: the effect of a pharmacist on post-admission ward rounds |
| Q36822271 | Improving medication reconciliation in the outpatient setting |
| Q42648529 | Improving patient safety through information technology |
| Q36424090 | Improving patient safety through the systematic evaluation of patient outcomes |
| Q48534445 | Improving patient safety using the sterile cockpit principle during medication administration: a collaborative, unit-based project. |
| Q44923283 | Improving self-reporting of adverse drug events in a West Virginia hospital |
| Q45332699 | Improving the bar-coded medication administration system at the Department of Veterans Affairs |
| Q50913583 | In-hospital medication reviews reduce unidentified drug-related problems. |
| Q34052619 | Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients |
| Q48731827 | Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting. |
| Q33864644 | Incidence and types of preventable adverse events in elderly patients: population based review of medical records |
| Q33875096 | Incidence of clinically relevant medication errors in the era of electronically prepopulated medication reconciliation forms: a retrospective chart review |
| Q35412906 | Incidence of medication errors in a Moroccan medical intensive care unit |
| Q40500669 | Incidence, Morbidity, and Costs of Human Metapneumovirus Infection in Hospitalized Children |
| Q37419357 | Incidence, preventability, and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study |
| Q40979038 | Information resources used in antimicrobial prescribing |
| Q35525409 | Information technology and medication safety: what is the benefit? |
| Q38109008 | Initiation of cholinesterase inhibitors in an inpatient setting |
| Q37087377 | Inpatient medication reconciliation at admission and discharge: A retrospective cohort study of age and other risk factors for medication discrepancies |
| Q24244656 | Interventions for reducing medication errors in children in hospital |
| Q24202278 | Interventions for reducing medication errors in hospitalised adults |
| Q36282467 | Intravenous fluid prescribing: Improving prescribing practices and documentation in line with NICE CG174 guidance |
| Q34577643 | Involving intensive care unit nurses in a proactive risk assessment of the medication management process |
| Q39759310 | Is computerized physician order entry use associated with a decrease in hospital resource utilization in hospitals that care for children? |
| Q33653418 | Is the ICU staff satisfied with the computerized physician order entry? A cross-sectional survey study |
| Q37062442 | Just what the doctor ordered. Review of the evidence of the impact of computerized physician order entry system on medication errors |
| Q35573267 | Knowledge and awareness of adverse drug reactions and pharmacovigilance practices among healthcare professionals in Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia |
| Q83130823 | Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran |
| Q34724676 | Laboratory monitoring of drugs at initiation of therapy in ambulatory care |
| Q36851125 | Laboratory-Confirmed Rotavirus Disease in Utah Children: Clinical and Economic Impact of Rotavirus Vaccination. |
| Q42711410 | Let's talk about error |
| Q42766669 | Let's talk about error |
| Q33787843 | Leveraging Food and Drug Administration Adverse Event Reports for the Automated Monitoring of Electronic Health Records in a Pediatric Hospital |
| Q37153323 | Linking joint commission inpatient core measures and national patient safety goals with evidence |
| Q47577721 | Measurement of selected preventable adverse drug events in electronic health records: Toward developing a complexity score |
| Q57302639 | Mechanisms of Adverse Drug Reactions |
| Q41687792 | Medical information systems and their importance in managed care |
| Q36292584 | Medication Error Disclosure and Attitudes to Reporting by Healthcare Professionals in a Sub-Saharan African Setting: A Survey in Uganda |
| Q55122200 | Medication Interaction and Physicians' Compliance Assessment through Medication Reconciliation Forms in a University Affiliated Hospital. |
| Q47931698 | Medication Safety in the Operating Room: A Survey of Preparation Methods and Drug Concentration Consistencies in Children's Hospitals in the United States |
| Q41690469 | Medication dosing errors and associated factors in hospitalized pediatric patients from the South Area of the West Bank - Palestine |
| Q38091147 | Medication errors in elderly acute care--a systematic review |
| Q80236372 | Medication errors in inpatient pharmacy operations and technologies for improvement |
| Q47426699 | Medication errors resulting in harm: Using chargemaster data to determine association with cost of hospitalization and length of stay |
| Q36237520 | Medication errors: hospital pharmacist perspective |
| Q24186116 | Medication review in hospitalised patients to reduce morbidity and mortality |
| Q24200610 | Medication review in hospitalised patients to reduce morbidity and mortality |
| Q24234492 | Medication review of hospitalized patients to prevent morbidity and mortality |
| Q35527756 | Medication safety program reduces adverse drug events in a community hospital |
| Q35955711 | Medication use in the context of everyday living as understood by seniors |
| Q33715099 | Medication-related emergency department visits and hospitalizations among older adults |
| Q33796209 | Medication-related visits in a pediatric emergency department: an 8-years retrospective analysis. |
| Q33633627 | Medication-wide association studies |
| Q83129680 | Medicine-related problems resulting in emergency department visits |
| Q33581183 | Meropenem. A pharmacoeconomic review of its use in serious infections |
| Q38048725 | Methodologies for the detection of adverse drug reactions: comparison of hospital databases, chart review and spontaneous reporting |
| Q35576805 | Methodology and rationale for the measurement of harm with trigger tools |
| Q34458560 | Methods and systems to detect adverse drug reactions in hospitals |
| Q34259525 | Mining multi-item drug adverse effect associations in spontaneous reporting systems |
| Q34532138 | Motor Activity in Aging: An Integrated Approach for Better Quality of Life |
| Q53573561 | Multidisciplinary approach to inpatient medication reconciliation in an academic setting. |
| Q84626710 | Multidisciplinary coordination to ensure correct patient medication: medication reconciliation |
| Q91674078 | Naranjo Question Answering using End-to-End Multi-task Learning Model |
| Q37784799 | Nature, occurrence and consequences of medication-related adverse events during hospitalization: a retrospective chart review in the Netherlands |
| Q28681788 | Novel data-mining methodologies for adverse drug event discovery and analysis |
| Q55718020 | Nurses' Perceived Skills and Attitudes About Updated Safety Concepts: Impact on Medication Administration Errors and Practices. |
| Q52800450 | Nurses' attitudes and spontaneous adverse drug reaction reporting: a case-control study in Portugal. |
| Q37598530 | Occurrence of adverse, often preventable, events in community hospitals involving nephrotoxic drugs or those excreted by the kidney |
| Q43748466 | Olanzapine-induced rhabdomyolysis |
| Q34884812 | Opioid medication errors in pediatric practice: four years' experience of voluntary safety reporting. |
| Q38736664 | Optimization of Geriatric Pharmacotherapy: Role of Multifaceted Cooperation in the Hospital Setting |
| Q24796204 | Optimizing antibiotic therapy in the intensive care unit setting |
| Q41282059 | Overall prescription medication use among adults: findings from the Survey of the Health of Wisconsin. |
| Q45259355 | Oxymorphone extended release does not affect CYP2C9 or CYP3A4 metabolic pathways |
| Q36943218 | Pathogenic role of natural killer T and natural killer cells in acetaminophen-induced liver injury in mice is dependent on the presence of dimethyl sulfoxide |
| Q34764219 | Patient risk factors for developing a drug-related problem in a cardiology ward. |
| Q38526913 | Patient safety and quality of care in developing countries in Southeast Asia: a systematic literature review. |
| Q35550962 | Patient safety in geriatrics: a call for action. |
| Q56832617 | Patientensicherheit durch computerbasierte Arzneimittelinformationen |
| Q28199533 | Patients' knowledge of adverse reactions to current medications |
| Q37636450 | Patterns and determinants of cardiovascular drug utilization in coronary care unit patients of a tertiary care hospital. |
| Q53701214 | Patterns, predictors and preventability of adverse drug reactions in the coronary care unit of a tertiary care hospital. |
| Q46961094 | People's attitudes, beliefs, and experiences regarding polypharmacy and willingness to Deprescribe. |
| Q28194005 | Perception of the risk of adverse drug reactions: differences between health professionals and non health professionals |
| Q73738563 | Performance of community pharmacy drug interaction software |
| Q33843430 | Performance of different data sources in identifying adverse drug events in hospitalized patients |
| Q36310182 | Personalized medicine in breast cancer: a systematic review |
| Q34938911 | Personalizing health care: feasibility and future implications |
| Q35140003 | Pharmaceutical care: pharmacy involvement in prescribing in an acute-care hospital |
| Q86167264 | Pharmacist-managed inpatient discharge medication reconciliation: a combined onsite and telepharmacy model |
| Q45235424 | Pharmacists' decision to undertake a mid-career residency. |
| Q37688038 | Pharmacoeconomics and aging |
| Q37151528 | Pharmacogenetic testing: Current Evidence of Clinical Utility |
| Q35955515 | Pharmacogenomic testing: relevance in medical practice: why drugs work in some patients but not in others |
| Q34574008 | Pharmacogenomic testing: the cost factor. |
| Q33959388 | Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors |
| Q34180945 | Pharmacokinetics and pharmacodynamics of low-molecular-weight heparins and glycoprotein IIb/IIIa receptor antagonists in renal failure |
| Q28542923 | Pharmacotherapy for adverse events reduces the length of hospital stay in patients admitted to otolaryngology ward: a single arm intervention study |
| Q38393021 | Pharmacovigilance in child and adolescent psychiatry |
| Q33791800 | Physician order entry or nurse order entry? Comparison of two implementation strategies for a computerized order entry system aimed at reducing dosing medication errors |
| Q52805751 | Physicians' attitudes and adverse drug reaction reporting : a case-control study in Portugal. |
| Q34061880 | Polypharmacy and hospitalization among older home care patients |
| Q31137297 | Population Analysis of Adverse Events in Different Age Groups Using Big Clinical Trials Data |
| Q53960935 | Potential drug-drug interactions and adverse drug reactions in dermatological inpatients. |
| Q83463179 | Potential drug-drug interactions associated with prolonged stays in the intensive care unit: a retrospective cohort study |
| Q37821154 | Potential for electronic health records and online social networking to redefine medical research |
| Q37688024 | Potentially inappropriate medication in elderly hospitalized patients |
| Q38715907 | Potentially inappropriate prescriptions in patients admitted to a psychiatric hospital. |
| Q49171317 | Precision Dosing: Public Health Need, Proposed Framework, and Anticipated Impact. |
| Q99365057 | Predicting the frequencies of drug side effects |
| Q46018490 | Predictors of 30- and 90-day readmission following craniotomy for malignant brain tumors: analysis of nationwide data. |
| Q92332791 | Prescribing errors in electronic prescriptions for outpatients intercepted by pharmacists and the impact of prescribing workload on error rate in a Chinese tertiary-care women and children's hospital |
| Q50791340 | Prescription and transcription errors in multidose-dispensed medications on discharge from hospital: an observational and interventional study. |
| Q53368020 | Pressure ulcers induced by drug administration: A new concept and report of four cases in elderly patients. |
| Q64245917 | Prevalence and Sources of Errors in Positive Airway Pressure Therapy Provisioning |
| Q33370507 | Prevalence and characteristics of adverse drug reactions in neurosurgical intensive care patients |
| Q34714007 | Prevalence of adverse drug reactions at a private tertiary care hospital in south India |
| Q36787242 | Prevalence of polypharmacy and drug interaction among hospitalized patients: opportunities and responsabilities in pharmaceutical care |
| Q45283800 | Prevalence of potentially severe drug-drug interactions in ambulatory patients with dyslipidaemia receiving HMG-CoA reductase inhibitor therapy |
| Q36034371 | Prevalence, Nature, Severity and Risk Factors for Prescribing Errors in Hospital Inpatients: Prospective Study in 20 UK Hospitals |
| Q37472022 | Prevalence, incidence and nature of prescribing errors in hospital inpatients: a systematic review. |
| Q43480310 | Preventability of adverse drug events involving multiple drugs using publicly available clinical decision support tools. |
| Q39379671 | Prevention of Medication Errors in Hospitalized Patients: The Japan Adverse Drug Events Study. |
| Q51366714 | Prevention of adverse drug events: a decade of progress in patient safety. |
| Q51785199 | Prevention of adverse drug reactions in intensive care patients by personal intervention based on an electronic clinical decision support system. |
| Q33772759 | Prevention of adverse events in hospitalized patients using an antimicrobial review program |
| Q56832627 | Prioritising the prevention of medication handling errors |
| Q34980368 | Proactive error prevention in the intensive care unit |
| Q36967183 | Propofol-associated QTc prolongation |
| Q58749279 | Prospective Validation of Clinical Criteria to Identify Emergency Department Patients at High Risk for Adverse Drug Events |
| Q40692156 | Prospective cohort study of adverse events monitored by hospital pharmacists. Hospital Adverse Event Monitoring Study (HAEMS) Group |
| Q35228977 | Prospective observational evaluation of incidences and implications of drug-drug interactions induced adverse drug reactions in critically ill patients |
| Q43749235 | Proton pump inhibitors are associated with hypersensitivity reactions to drugs in hospitalized patients: a nested case-control in a retrospective cohort study |
| Q35771493 | QT prolongation with antimicrobial agents: understanding the significance |
| Q35464593 | Quality indicators for safe medication preparation and administration: a systematic review |
| Q37427313 | RETRACTED: Meta-analysis on the efficacy of tourniquet on ankle trauma surgery |
| Q35289332 | Ranking adverse drug reactions with crowdsourcing. |
| Q24796333 | Rational use of computerized protocols in the intensive care unit |
| Q26822804 | Rational use of medicine in the pediatric age group: A summary on the role of clinical pharmacists |
| Q74221889 | Reasons to question psychologist prescribing |
| Q81099433 | Recognition and management of potential drug-drug interactions in patients on internal medicine wards |
| Q28651397 | Recognition and reporting of suspected adverse drug reactions by surveyed healthcare professionals in Uganda: key determinants |
| Q36508509 | Recognition of adverse drug events in older hospitalized medical patients. |
| Q73657613 | Recognizing the institutional benefits of bar-code point-of-care technology |
| Q36767122 | Reconcilable differences: correcting medication errors at hospital admission and discharge |
| Q88687889 | Reduced Effectiveness of Interruptive Drug-Drug Interaction Alerts after Conversion to a Commercial Electronic Health Record |
| Q34413689 | Reducing excessive medication administration in hospitalized adults with renal dysfunction |
| Q33935653 | Reducing medication errors in hospitals: a peer review organization collaboration |
| Q34806653 | Return on investment for a computerized physician order entry system |
| Q38066020 | Review article: the evolving role of information technology in perioperative patient safety |
| Q36539351 | Reviewing the benefits and costs of electronic health records and associated patient safety technologies |
| Q46493523 | Risk factors for adverse drug events: a 10-year analysis |
| Q84269736 | Risk factors for prescribing and transcribing medication errors among elderly patients during acute hospitalization: a cohort, case-control study |
| Q37784486 | Risk of potential drug-drug interactions among Brazilian elderly: a population-based, cross-sectional study. |
| Q92740177 | Root Cause Analysis of Blunders in Anesthesia |
| Q31809004 | SSM Health Care clinical collaboratives: improving the value of patient care in a health care system |
| Q48703652 | Seizures in children following an apparent life-threatening event. |
| Q41927200 | Severe Delayed Drug Reactions: Role of Genetics and Viral Infections. |
| Q37323856 | Spontaneous normal sinus rhythm conversion using integrative medicine in atrial fibrillation |
| Q44738105 | Standardization as a mechanism to improve safety in health care |
| Q46046369 | Structural Basis of Single-Nucleotide Polymorphisms in Cytochrome P450 2C9. |
| Q92074968 | Structured override reasons for drug-drug interaction alerts in electronic health records |
| Q37476148 | Study of medication errors on a community hospital oncology ward |
| Q36823963 | Systematic Analysis of Adverse Event Reports for Sex Differences in Adverse Drug Events |
| Q93335115 | Systematic review of computerized prescriber order entry and clinical decision support |
| Q48236622 | Systematic review of predictive risk models for adverse drug events in hospitalised patients |
| Q73104602 | Systematic root cause analysis of adverse drug events in a tertiary referral hospital |
| Q34385787 | Teucrium polium and kidney |
| Q59207911 | Texas pharmacists’ opinions on reporting serious adverse drug events to the Food and Drug Administration: a qualitative study |
| Q34537662 | The AmpliChip CYP450 genotyping test: Integrating a new clinical tool |
| Q41993304 | The Cost of Penicillin Allergy Evaluation |
| Q47895252 | The Effects of Cannabis on Inpatient Agitation, Aggression, and Length of Stay |
| Q36829159 | The Emergence of the Trigger Tool as the Premier Measurement Strategy for Patient Safety |
| Q50106215 | The Impact of Provider Networks on the Co-Prescriptions of Interacting Drugs: A Claims-Based Analysis. |
| Q37242736 | The Importance of Medication Errors Reporting in Improving the Quality of Clinical Care Services |
| Q39465257 | The WHO 'Roll Back Malaria Project': planning for adverse event monitoring in Africa |
| Q34098649 | The burden of inherited leukodystrophies in children |
| Q37590271 | The causes of and factors associated with prescribing errors in hospital inpatients: a systematic review. |
| Q38237743 | The cost of opioid-related adverse drug events |
| Q41523902 | The cost-saving effect and prevention of medication errors by clinical pharmacist intervention in a nephrology unit. |
| Q44907380 | The costs of adverse drug events in community hospitals |
| Q35338080 | The development of a computerised equipment and drug calculator for use in resuscitation |
| Q39012333 | The economic burden of nurse-sensitive adverse events in 22 medical-surgical units: retrospective and matching analysis. |
| Q74314185 | The economics of quality--a practical approach |
| Q43880567 | The effect of Computerized Physician Order Entry and decision support system on medication errors in the neonatal ward: experiences from an Iranian teaching hospital |
| Q36608262 | The effect of computerized physician order entry with clinical decision support on the rates of adverse drug events: a systematic review |
| Q44107915 | The effect of medication reconciliation in elderly patients at hospital discharge |
| Q35241119 | The effect of pharmacist-led medication review in high-risk patients in the emergency department: an evaluation protocol |
| Q35199502 | The epidemiology of preventable adverse drug events: a review of the literature. |
| Q47403196 | The frequency and nature of medication errors in hospitalized patients with acute coronary syndrome |
| Q34741545 | The genetic basis of variability in drug responses |
| Q39274064 | The impact of computerized physician order entry on medication error prevention |
| Q55261032 | The impact of pharmacists-led medicines reconciliation on healthcare outcomes in secondary care: A systematic review and meta-analysis of randomized controlled trials. |
| Q41521130 | The impact of the CYP2D6 gene polymorphism on the risk of pemphigoid |
| Q36265936 | The incidence of prescribing errors in hospital inpatients: an overview of the research methods |
| Q45165452 | The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals |
| Q89231794 | The national cost of adverse drug events resulting from inappropriate medication-related alert overrides in the United States |
| Q86168798 | The pattern of the discovery of medication errors in a tertiary hospital in Hong Kong |
| Q45877673 | The quality and economic impact of disruptive behaviors on clinical outcomes of patient care |
| Q35817019 | The role of cost-effectiveness analysis in the era of pharmacogenomics |
| Q41656963 | The role of reactive drug metabolites in immune-mediated adverse drug reactions |
| Q78064780 | The role of the French community pharmacist in drug dispensing |
| Q34005865 | The safety profile of the fluoroquinolones. |
| Q36176150 | The sensitivity of adverse event cost estimates to diagnostic coding error |
| Q36461654 | The sublanguage of cross-coverage |
| Q36463186 | The utility of adding retrospective medication profiling to computerized provider order entry in an ambulatory care population |
| Q36582619 | Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance |
| Q40563321 | Therapy related hospital admission in patients on polypharmacy in Singapore: a pilot study |
| Q30796597 | Toward enhanced pharmacovigilance using patient-generated data on the internet |
| Q21133887 | Toxic element contamination of natural health products and pharmaceutical preparations |
| Q37718523 | Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell-Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive In Vitro Systems for Drug-Induced Liver Injury. |
| Q36487908 | Trends in adverse reactions to trimethoprim-sulfamethoxazole |
| Q30978232 | US economic revolution. Mapping the future of healthcare |
| Q93761291 | Une once de prévention: Prescription pour un système de santé en difficulté |
| Q45902688 | Use of a trigger tool to detect adverse drug reactions in an emergency department. |
| Q34371734 | Use of an automated clinical management system improves outpatient immunosuppressive care following liver transplantation |
| Q57317289 | Using Patient Safety Indicators to Estimate the Impact of Potential Adverse Events on Outcomes |
| Q55547106 | Using a Clinical Data Repository to Estimate the Frequency and Costs of Adverse Drug Events. |
| Q30308660 | Using a clinical data repository to estimate the frequency and costs of adverse drug events |
| Q73122669 | Using a market model to track advances in patient safety |
| Q45583087 | Using an anesthesia information management system to prove a deficit in voluntary reporting of adverse events in a quality assurance program |
| Q52135100 | Using an improvement model to reduce adverse drug events in VA facilities. |
| Q30650277 | Using computerized data to identify adverse drug events in outpatients |
| Q41842075 | Using information technology to reduce rates of medication errors in hospitals |
| Q44985930 | Using lean to improve medication administration safety: in search of the "perfect dose". |
| Q34474073 | Using protocols to improve the outcomes of mechanically ventilated patients. Focus on weaning and sedation |
| Q36326039 | Utilising statutory health insurance data to evaluate pharmaceutical interventions in secondary care - a pilot study |
| Q50664135 | Utilizing pharmacogenetics in psychiatry: the time has come. |
| Q55510191 | Validation of a score to identify inpatients at risk of a drug-related problem during a 4-year period. |
| Q64931049 | Validation of the assessment of risk tool: patient prioritisation technology for clinical pharmacist interventions. |
| Q30727438 | Variations in the Use of Perioperative Multimodal Analgesic Therapy |
| Q74296984 | Wake-up call--standardization is crucial to eliminating medication errors |
| Q34057639 | What can we learn from consumer reports on psychiatric adverse drug reactions with antidepressant medication? Experiences from reports to a consumer association |
| Q35210855 | What do we know about medication errors in inpatient psychiatry? |
| Q37083905 | Which adverse events are related to health care during hospitalization in elderly inpatients? |
| Q52372019 | Why Clinicians Don't Report Adverse Drug Events: Qualitative Study. |
| Q34686507 | Will decision support in medications order entry save money? A return on investment analysis of the case of the Hong Kong hospital authority |
| Q56639674 | Zur H�ufigkeit und Vermeidbarkeit von t�dlichen unerw�nschten Arzneimittelwirkungen |
| Q81885861 | [Adverse drug effects: a prospective study by Apnet performed in seven emergency care units in France: propositions for preventive measures] |
| Q80221251 | [Adverse effects in hospital healthcare. A critical review] |
| Q79430467 | [Clinical and economic impact of the pharmacy resident incorporation into the healthcare team] |
| Q81439368 | [Comparative study of errors in electronic versus manual prescription] |
| Q77745371 | [Detection and evaluation of adverse drug reactions] |
| Q81591680 | [Medical and socio-economical impact of drug-induced adverse reactions] |
| Q79192830 | [Pharmacovigilance in a paediatric intensive care unit] |
| Q80523141 | [Prospective assessment of drug interactions in hospitalized patients using a computer programme] |
| Q52807188 | [The pharmacovigilance system in Portugal (its establishment and development)]. |
Search more.